Background Significant aortic regurgitation (AR) is rare following surgical aortic valve
replacement and has been associated with worse outcome. Following transcatheter aortic valve …

Background and aims Low-density lipoprotein cholesterol (LDL-C) is a major contributor to
cardiovascular disease. In the Dyslipidemia International Study II (DYSIS II), we determined …

Background and aims There is an inconsistency between international guidelines on lipid-lowering
treatment regarding whether to pursue LDL-C treatment targets or to focus on the …

Objectives To determine predictors of permanent pacemaker (PPM) implantation up to 30
days after transcatheter aortic valve implantation (TAVI) in a prospective multicenter registry. …

Objective To examine the prevalence and impact of concomitant coronary artery disease (CAD)
on short-term outcome after transcatheter aortic valve implantation (TAVI). Background …

Objectives : The purpose of this study was to evaluate the efficacy and outcome of transcatheter
aortic valve implantation (TAVI) in patients with low-flow, low-gradient aortic stenosis (LG…

Background Patients with coronary heart disease (CHD) and survivors of acute coronary
syndrome (ACS) are at very high risk for adverse cardiovascular events. Lowering low-density …

BACKGROUND: A significant proportion of patients undergoing transcatheter aortic valve
implantation (TAVI) have concomitant peripheral arterial disease (PAD), which plays a crucial …

BACKGROUND: Catheter ablation (CA) is considered the treatment of choice for patients
with atrioventricular nodal reentrant tachycardia (AVNRT). However, there is a tendency to …

… The author(s) declared the following potential conflicts of interest with respect to the research,
authorship, and/or publication of this article: Martin Horack has received consultancy fees …